Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Changing proportions of paucibacillary leprosy cases in global leprosy case notification

Butlin CR, Lockwood DNJ. Lepra. Leprosy review. 2020; 91 (3) : 255-261.
Download PDF
Publication

Hansen’s Disease: differences in clinical presentation among Latin American and South East Asian born patients identified in Los Angeles County, California (1995–2016)

Croker C, Phommasith J, Jerskey RS, et al. Lepra. Leprosy review. 2020; 91 (3) : 244-254.
Download PDF
Publication

The adverse drug effects of dapsone therapy in leprosy: a systematic review

Hilder R, Lockwood D. Lepra. Leprosy review. 2020; 91 (3) : 232-243.
Download PDF
Publication

Excess of deaths of leprosy-affected people

Butlin C. Lepra. Leprosy review. 2020; 91 (2) : 220-223.
Download PDF
Publication

Generalized idiopathic atrophodema of Pasini and Pierini misdiagnosed as relapse of disease in a patient with borderline tuberculoid leprosy

Pradhan S, Dash G, Sirka CS, et al. Lepra. Leprosy review. 2020; 91 (2) : 215-219.
Download PDF
Publication

Elephantiasis nostras verrucosa secondary to leprous lymphadenopathy; a case report

Jindal R, Shirazi N, Chauhan P, et al. Lepra. Leprosy review. 2020; 91 (2) : 209-214.
Download PDF
Publication

Hansen’s Disease presenting as tenosynovitis

Suvarna P, Nayak U. K. S, Shenoi S, et al. Lepra. Leprosy review. 2020; 91 (2) : 204-208.
Download PDF
Publication

Uncommon adverse effects of thalidomide: seldom reported phenomena in leprosy

Narang I, Ailawadi P, Garg V. Lepra. Leprosy review. 2020; 91 (2) : 200-203.
Download PDF
Publication

Socio-medical perspectives on leprosy in Indian religions

M. S, Rao P, G. K. Lepra. Leprosy review. 2020; 91 (2) : 190-199.
Download PDF
Publication

“We are not afraid anymore…” Capturing the most significant change of the Leprosy Friendly Village approach in North Sulawesi, Indonesia

Budiawan T, Ferdiana A, Daendel S, et al. Lepra. Leprosy review. 2020; 91 (2) : 173-189.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 319
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD